UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 183

Sortiert nach

THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets

PloS one, 2022-12, Vol.17 (12), p.e0278365-e0278365

2022

Volltextzugriff (PDF)

Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils

The Journal of immunology (1950), 2014-06, Vol.192 (11), p.5031-5038

2014

Volltextzugriff (PDF)

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

Blood, 2009-04, Vol.113 (14), p.3154-3160

2009

Volltextzugriff (PDF)

Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia

Haematologica (Roma), 2019-06, Vol.104 (6), p.1237

2019

Volltextzugriff (PDF)

Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain

American journal of physiology. Regulatory, integrative and comparative physiology, 2018-04, Vol.314 (4), p.R611-R622

2018

Volltextzugriff (PDF)

CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis

PloS one, 2013-06, Vol.8 (6), p.e65805-e65805

2013

Volltextzugriff (PDF)

Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production

PloS one, 2012-02, Vol.7 (2), p.e31357-e31357

2012

Volltextzugriff (PDF)

B cells and antibodies in refractory immune thrombocytopenia

British journal of haematology, 2023-10, Vol.203 (1), p.43-53

2023

Volltextzugriff (PDF)

The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?

Transfusion medicine reviews, 2008-04, Vol.22 (2), p.103-116

2008

Volltextzugriff (PDF)

TEMRA: the CD8 subset in chronic ITP?

Blood, 2023-05, Vol.141 (20), p.2409-2410

2023

Volltextzugriff (PDF)

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

Blood, 2007-01, Vol.109 (1), p.155-158

2007

Volltextzugriff (PDF)

Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway

PloS one, 2013-08, Vol.8 (8), p.e71882-e71882

2013

Volltextzugriff (PDF)

Could antigen loss be a potential mechanism to explain antibody‐mediated immune suppression?

Transfusion (Philadelphia, Pa.), 2021-04, Vol.61 (4), p.1004-1006

2021

Volltextzugriff (PDF)

Antigen‐specific IgG subclass composition in recipient mice can indicate the degree of red blood cell alloimmunization as well as discern between primary and secondary immunization

Transfusion (Philadelphia, Pa.), 2023-03, Vol.63 (3), p.619-628

2023

Volltextzugriff (PDF)

Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice

The Journal of immunology (1950), 2024-05, Vol.212 (10), p.1531

2024

Volltextzugriff (PDF)

Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody‐mediated immune suppression or enhancement in a murine model

Transfusion (Philadelphia, Pa.), 2023-04, Vol.63 (4), p.696-702

2023

Volltextzugriff (PDF)

A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy

Blood, 2006-04, Vol.107 (7), p.2976-2983

2006

Volltextzugriff (PDF)

The use of IVIg in fetal and neonatal alloimmune thrombocytopenia— Principles and mechanisms

Transfusion and apheresis science, 2020-02, Vol.59 (1), p.102710-102710, Article 102710

2020

Volltextzugriff (PDF)

Erythrocyte Saturation with IgG Is Required for Inducing Antibody-Mediated Immune Suppression and Impacts Both Erythrocyte Clearance and Antigen-Modulation Mechanisms

The Journal of immunology (1950), 2018-02, Vol.200 (4), p.1295-1305

2018

Volltextzugriff (PDF)

Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition

Blood, 2021-04, Vol.137 (15), p.2114-2124

2021

Volltextzugriff (PDF)

Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in mice

Blood, 2016-08, Vol.128 (8), p.1076-1080

2016

Volltextzugriff (PDF)

Targeting FcγRs to treat antibody-dependent autoimmunity

Autoimmunity reviews, 2016-06, Vol.15 (6), p.510-512

2016

Volltextzugriff (PDF)

Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression

Blood, 2024-02, Vol.143 (9), p.807

2024

Volltextzugriff (PDF)

GPIbα is required for platelet-mediated hepatic thrombopoietin generation

Blood, 2018-08, Vol.132 (6), p.622-634

2018

Volltextzugriff (PDF)

Intravenous immunoglobulin inhibits anti‐glycoprotein IIb‐induced platelet apoptosis in a murine model of immune thrombocytopenia

British journal of haematology, 2006-04, Vol.133 (1), p.78-82

2006

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(167)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(183)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(102)
Hematology
(74)
Humans
(70)
Animals
(65)
Mice
(60)
Female
(41)
Biological And Medical Sciences
(36)
Medical Sciences
(33)
Mice, Inbred C57bl
(28)
Male
(26)
Disease Models, Animal
(25)
Purpura, Thrombocytopenic, Idiopathic - Immunology
(25)
Immunoglobulins, Intravenous - Therapeutic Use
(22)
Immunology
(21)
Hematologic And Hematopoietic Diseases
(19)
Mice, Knockout
(18)
Purpura, Thrombocytopenic, Idiopathic - Therapy
(18)
Adult
(16)
Mice, Inbred Balb C
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets

Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia

Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain

CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis

Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production

B cells and antibodies in refractory immune thrombocytopenia

The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?

TEMRA: the CD8 subset in chronic ITP?

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway

Could antigen loss be a potential mechanism to explain antibody‐mediated immune suppression?

Antigen‐specific IgG subclass composition in recipient mice can indicate the degree of red blood cell alloimmunization as well as discern between primary and secondary immunization

Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice

Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody‐mediated immune suppression or enhancement in a murine model

A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy

The use of IVIg in fetal and neonatal alloimmune thrombocytopenia— Principles and mechanisms

Erythrocyte Saturation with IgG Is Required for Inducing Antibody-Mediated Immune Suppression and Impacts Both Erythrocyte Clearance and Antigen-Modulation Mechanisms

Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition

Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in mice

Targeting FcγRs to treat antibody-dependent autoimmunity

Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression

GPIbα is required for platelet-mediated hepatic thrombopoietin generation

Intravenous immunoglobulin inhibits anti‐glycoprotein IIb‐induced platelet apoptosis in a murine model of immune thrombocytopenia

Suchergebnisse filtern